Search Results - "Goodman, WG"

Recent developments in the management of secondary hyperparathyroidism by GOODMAN, William G

“…Abstract only…”
Get full text

Managing phosphate retention: is a change necessary? by Salusky, Isidro B., Goodman, William G.

Get full text

Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis by Block, Geoffrey A, Martin, Kevin J, de Francisco, Angel L.M, Turner, Stewart A, Avram, Morrell M, Suranyi, Michael G, Hercz, Gavril, Cunningham, John, Abu-Alfa, Ali K, Messa, Piergiorgio, Coyne, Daniel W, Locatelli, Francesco, Cohen, Raphael M, Evenepoel, Pieter, Moe, Sharon M, Fournier, Albert, Braun, Johann, McCary, Laura C, Zani, Valter J, Olson, Kurt A, Drüeke, Tilman B, Goodman, William G

“…Hypercalcemia and hyperphosphatemia often complicate secondary hyperparathyroidism therapy in patients who are receiving dialysis. Unlike vitamin D and…”
Get full text

Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis by Goodman, William G, Goldin, Jonathan, Kuizon, Beatriz D, Yoon, Chun, Gales, Barbara, Sider, Donna, Wang, Yan, Chung, Joanie, Emerick, Aletha, Greaser, Lloyd, Elashoff, Robert M, Salusky, Isidro B

“…The life span of adults with end-stage renal disease is reduced, and cardiovascular disease accounts for approximately half the deaths among adults undergoing…”
Get full text

Achieving NKF-K/DOQI™ bone metabolism and disease treatment goals with cinacalcet HCl by Moe, Sharon M., Chertow, Glenn M., Coburn, Jack W., Quarles, L. Darryl, Goodman, William G., Block, Geoffrey A., DrEke, Tilman B., Cunningham, John, Sherrard, Donald J., Mccary, Laura C., Olson, Kurt A., Turner, Stewart A., Martin, Kevin J.

“…Achieving NKF-K/DOQI™ bone metabolism and disease treatment goals with cinacalcet HCl. The National Kidney Foundation's Kidney Disease Outcomes Quality…”
Get full text

Role of the calcium-sensing receptor in parathyroid gland physiology by Chen, Randolph A, Goodman, William G

“…The calcium-sensing receptor (CaSR) represents the molecular mechanism by which parathyroid cells detect changes in blood ionized calcium concentration and…”
Get more information

PTH(1-84)/PTH(7-84): a balance of power by Friedman, Peter A, Goodman, William G

“…This review considers many new basic and clinical aspects of parathyroid hormone (PTH). We focus especially on the identification of PTH fragments and how they…”
Get more information

Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry by Lehmann, Gabriele, Stein, Günter, Hller, Manfred, Schemer, Rudolf, Ramakrishnan, Kastooriranganathan, Goodman, William G.

“…Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry. Parathyroid hormone (PTH) measurements…”
Get full text

Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl by Moe, Sharon M., Cunningham, John, Bommer, Jürgen, Adler, Stephen, Rosansky, Steven J., Urena-Torres, Pablo, Albizem, Moetaz B., Guo, Matthew D., Zani, Valter J., Goodman, William G., Sprague, Stuart M.

“…Background. Patients with secondary hyperparathyroidism often require therapy that provides long-term control of parathyroid hormone concentrations without…”
Get full text

The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism by GOODMAN, William G, HLADIK, Gerald A, TURNER, Stewart A, BLAISDELL, Peter W, GOODKIN, David A, WEI LIU, BARRI, Yousri M, COHEN, Raphael M, COBURN, Jack W

“…Treatment with vitamin D sterols can lower plasma parathyroid hormone (PTH) in many patients with secondary hyperparathyroidism due to end-stage renal disease,…”
Get full text

The Consequences of Uncontrolled Secondary Hyperparathyroidism and Its Treatment in Chronic Kidney Disease by Goodman, William G.

“…ABSTRACT Secondary hyperparathyroidism (HPT) is a common complication of chronic kidney disease (CKD) and a frequent cause of clinically significant bone…”
Get full text

The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism by Lindberg, Jill S., Moe, Sharon M., Goodman, William G., Coburn, Jack W., Sprague, Stuart M., Liu, Wei, Blaisdell, Peter W., Brenner, Robert M., Turner, Stewart A., Martin, Kevin J.

“…The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism. A need exists for a therapy that lowers…”
Get full text

Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols by SALUSKY, Isidro B, GOODMAN, William G, SAHNEY, Shobha, GALES, Barbara, PERILLOUX, Ashley, WANG, He-Jing, ELASHOFF, Robert M, JÜPPNER, Harald

“…Little is known about the impact of various phosphate binders on the skeletal lesions of secondary hyperparathyroidism (2 degrees HPT). The effects of calcium…”
Get full text

Medical management of secondary hyperparathyroidism in chronic renal failure by GOODMAN, William G

“…Abnormalities in calcium and phosphorus metabolism are common, and metabolic bone disease develops often in patients with chronic renal failure (CRF)…”
Get full text

Cardiovascular calcification in end‐stage renal disease by Salusky, Isidro B., Goodman, William G.

“…Cardiovascular diseases are common in patients with end‐stage renal disease (ESRD) and cardiovascular morbidity and mortality among dialysis patients are…”
Get full text

Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis by Salusky, Isidro B., Goodman, William G., Kuizon, Beatriz D., Lavigne, Jeffrey R., Zahranik, Richard J., Gales, Barbara, Wang, He-Jing, Elashoff, Robert M., Jüppner, Harald

“…Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis…”
Get full text

Calcimimetic agents and secondary hyperparathyroidism: rationale for use and results from clinical trials by GOODMAN, William G

“…Calcimimetic agents are small organic molecules that act as allosteric activators of the calcium sensing receptor (CaSR). In parathyroid cells, they lower the…”
Get full text

Calcium-sensing receptors by Goodman, William G

“…It is now known that variations in extracellular calcium concentration exert diverse physiologic effects in a variety of tissues that are mediated by a…”
Get more information

Vascular calcification in chronic renal failure by Goodman, William G

“…The data provided by Mazhar and colleagues support some of the earlier observations that secondary hyperparathyroidism or certain biochemical changes…”
Get full text

Vascular calcification in chronic kidney disease by Goodman, William G, London, Gerard, Amann, Kerstin, Block, Geoffrey A, Giachelli, Cecilia, Hruska, Keith A, Ketteler, Markus, Levin, Adeera, Massy, Ziad, McCarron, David A, Raggi, Paolo, Shanahan, Catherine Mary, Yorioka, Noriaki

Get full text